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We read with interest Charlie Poole’s commentary [1]
on our paper, “Redundant causation from a sufficient
cause perspective,”[2] in which he questions the utility
of the sufficient component cause (SCC) model for
examining differences between etiologic and excess
effects. Poole contends that the concept we term
“redundant causation” is uncomplicated and (we pre-
sume), well understood. He questions whether “it needs
to be explained in terms any deeper than those of
potential outcomes” [1]. His critique of our paper
focuses on our hypothetical and simplistic example of
sufficient causes (SCs) of liver cancer. To be of value,
Poole believes our example must be realistic and must
bring “aspects of the potential outcome and sufficient
cause models, and their interface, into sharp relief” [1].
His concerns raise larger issues about the roles of sim-
plifications and the SCC model in methods research in
general. We address each of these below.
Simplifications
As Poole suggests, the conceptual and mathematical
underpinnings of redundant causation (which we refer
to colloquially as “redundancy”) and its potential impact
on etiologic versus excess effects have been explained by
others in philosophy and epidemiology [3-10]. We dis-
agree, however, that redundancy is “uncomplicated”,
fully examined in the literature, or well understood by
epidemiologists. One purpose of our paper was to make
the discussion of redundancy more accessible to a broad
epidemiologic audience. To this end, we used a hypothe-
tical and intentionally simplified liver cancer example to
help crystallize this discussion for those who prefer
tangible examples.
Poole was bothered by many simplifications in our
liver cancer example, including the lack of competing
risks, lack of disease recurrence, lack of shared causal
components and presence of ubiquitous components.
Although these simplifications may be unrealistic, we
feel they were appropriate for illustration purposes.
Indeed, the use of simplifying assumptions is ubiquitous
in methodological work. To discover underlying princi-
ples, the complexity of real life situations must be con-
trolled. Charges of oversimplification, therefore, should
be grounded in a discussion of which simplifying
assumptions are legitimate and which are not.
It seems to us that simplifying assumptions are legiti-
mate if they are: (1) possible, or (2) impossible (or
highly unlikely), but violating the assumption does not
change the argument. For example, a monotonicity
assumption is often invoked in methods work; it is often
assumed that a risk factor is either causal or protective
for the disease, but not both. This assumption is legiti-
mate because it is possible. There are risk factors that
meet this assumption. One can validly illustrate a meth-
ods principle invoking this assumption because there
are realistic circumstances under which this principle
would hold. Once the principle is understood within
this context, the next step would be to examine the
impact of relaxing this assumption [11,12].
Another frequently invoked assumption is an infinitely
large sample size (see for example, [13]). This assump-
tion is, by definition, impossible - no study can have an
infinitely large sample. Nonetheless, this assumption can
be legitimate because it often does not change the prin-
ciple under investigation; it just allows the principle to
be explicated more clearly.
In our liver cancer example, we think that all the sim-
plifications meet the criteria for legitimate assumptions.
Our assumptions are either possible (e.g., that alcohol
consumption is the final component to complete the
* Correspondence: nicolle.gatto@pfizer.com
1Department of Epidemiology, Mailman School of Public Health, Columbia
University, New York, NY 10032 USA
Full list of author information is available at the end of the article
Gatto et al. Epidemiologic Perspectives & Innovations 2010, 7:7
http://www.epi-perspectives.com/content/7/1/7
© 2010 Gatto et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
sufficient cause), or impossible but do not change the
argument (e.g., that no one dies during the study period).
Ironically, in the methods literature, the absence of
redundancy is often invoked as a simplifying assump-
tion. Although Poole suggests that redundancy is well
understood, its inevitability is often disregarded in meth-
ods work. That is, “no redundancy” is an impossible
assumption that sometimes does change the principles
under study. This illegitimacy of the “no redundancy”
assumption became apparent when the effects of paral-
lelism on the assessment of synergy entered the litera-
ture [14] and is a problem, we think, in some of the
literature on mediation [15,16].
By invoking simplifying assumptions in our liver can-
cer example, we showed that the presence of even one
individual with redundant sufficient causes can lead to a
discrepancy between an etiologic and excess effect mea-
sure. To us, the next natural questions are “under what
circumstances will redundancy lead to large discrepan-
cies between etiologic and excess effects?” followed by
“how realistic are those circumstances"? We have begun
to address these additional questions (in manuscripts
that are in various states of preparation), and we hope
that other epidemiologists will be intrigued and help
round out the answers.
Utility of the SCC model
Many methodologic innovations in epidemiology have
been forged using POs. In recent years, drawing connec-
tions between POs and SCCs seems to have become a
topic of interest [10,12,17-24]. However, many of these
discussions start with a set of POs and then connect
them to an underlying general SCC model. We (the
authors) begin methodologic research by specifying the
directed acyclic graph (DAG) that depicts the relation-
ships we intend to examine. From there, we apply the
DAG rules to draw a SCC model that underlies the
DAG. The potential outcomes arise directly from that
specific SCC model and the prevalences of its compo-
nents. We recognize that our perspective on the links
among a DAG, SSC model, and set of POs is not typical;
we have begun to address this elsewhere [25,26].
The SCC model has been used to illustrate several
epidemiologic principles in the literature. For instance,
in the Modern Epidemiology text, Rothman and Green-
land use a SCC model to show how the strength of an
association is caused by the prevalence of the causal
partner [27] and to demonstrate the concepts of synergy
and parallelism – that the extent of synergy is deter-
mined by the prevalences of all partners of the synergis-
tic factors, and that additive interaction is synergy
minus parallelism [28]. Notably, the most recent version
of Modern Epidemiology invokes a simple SCC model
to describe how redundant causation arises [29].
The second purpose of our paper was to make the
discussion of redundancy more comprehensive. Like
parallelism, redundancy is most clearly seen through the
SCC lens. The SCC model makes clear: 1) how redun-
dancy arises, 2) that it is a naturally occurring, inevitable
phenomenon, and 3) which factors influence the propor-
tion of redundant individuals in a population for a parti-
cular disease at a particular point in time. POs allow us
to see the critical mathematical distinction between
disease etiology and excess, but do not allow us to see
what factors influence the distribution of the POs,
which ultimately drives the strength of the etiologic
effect and thus its discrepancy from the excess effect we
actually measure.
Conclusions
Our examination of redundancy shows that even in the
simplest (and perhaps most unrealistic) scenarios (e.g.
when none of the sufficient causes shares components
and there are no associations between components),
redundancy can influence our effect estimates. It
appears that the more complicated the SCC model (e.g.,
the more SCs, shared components, or associations
between components in the SCC model), the more
redundant individuals there will be, and the larger the
discrepancy between the etiologic and excess effects. We
do not believe that these principles could be revealed
using potential outcomes alone.
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